Finance

Beta
Lists
KTTA:NASDAQ
Pasithea Therapeutics Corp
$0.54
+0.33%
(+0.0018) 1D
$0.54
-1.55% (-0.0084)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KTTA...
Open
$0.53
High
$0.57
Low
$0.52
Mkt. cap
18.21M
Avg. vol.
411.81K
Volume
232.04K
52-wk high
$2.06
52-wk low
$0.28
EPS
-$1.98
Beta
0.25
Shares outstanding
33.41M
No. of employees
5
Open
$0.53
High
$0.57
Low
$0.52
Mkt. cap
18.21M
Avg. vol.
411.81K
Volume
232.04K
52-wk high
$2.06
52-wk low
$0.28
EPS
-$1.98
Beta
0.25
Shares outstanding
33.41M
No. of employees
5
News stories
From sources across the web
About Pasithea Therapeutics Corp
CEO-
Employees5
Founded2020
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Websitepasithea.com
Analyst ratings
Based on 1 analyst giving stock ratings to KTTA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for KTTA in the last 3 months
Highest
Current $0.54
$3.00 (+452.08%)
Average
$3.00 (+452.08%)
Lowest
$3.00 (+452.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sara Nik
H.C. Wainwright
Buy
Reiterated
$3.00
+452.1%
06/16/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.15M
1.36M
2.74M
2.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
1.75M
3.35M
1.93M
Operating expense
3.81M
3.11M
6.09M
4.88M
Total operating expenses
3.81M
3.11M
6.09M
4.88M
Operating income
-3.81M
-3.11M
-6.09M
-4.88M
Other non operating income
11.03K
55.49K
-64.17K
1.57M
EBT including unusual items
-3.72M
-3.04M
-10.11M
-2.87M
EBT excluding unusual items
-3.72M
-3.04M
-5.95M
-2.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.72M
-3.04M
-10.11M
-2.87M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.89
-0.12
Interest and investment income
54.42K
43.40K
182.13K
450.34K
Interest expense
-
-
-
-
Net interest expenses
54.42K
43.40K
182.13K
450.34K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.65M
-2.93M
-5.93M
-4.72M
Gain or loss from assets sale
-
-
103.32K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of KTTA
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer